180 Life Sciences Corp Stock price
Is 180 Life Sciences Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
180 Life Sciences Corp Stock Analysis
Analyst Opinions
7 Analysts have issued a 180 Life Sciences Corp forecast:
Analyst Opinions
7 Analysts have issued a 180 Life Sciences Corp forecast:
Don't miss a Thing! We will send you all news about 180 Life Sciences Corp directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
180 Life Sciences Corp. develops pharmaceuticals for chronic pain and inflammatory diseases. It operates as a clinical-stage biotechnology company focused on the development of novel drugs that fulfil unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded in 2016 and is headquartered in Menlo Park, CA.
| Head office | United States |
| CEO | Mr. Jordan |
| Employees | 4 |
| Founded | 2016 |
| Website | 180lifesciences.com |


